Rx Anipryl for Dogs Anipryl also known as L-Deprenyl, is a monoamine oxidase inhibitor used in dogs for treatment of Cushing’s Disease and canine cognitive dysfunction. It is indicated for the control of clinical signs associated with canine cognitive dysfunction syndrome (CDS) and control of clinical signs associated with uncomplicated canine pituitary dependent hyperadrenocorticism (PDH). Indicated for the control of signs associated with canine Cognitive Dysfunction syndrome (CDS) and control of clinical signs of uncomplicated pituitary dependent hyperadrenocorticism (PDH) Is a selective monoamine oxidase -B inhibitor, which could enhance catecholamine neuronactivity and increases dopamine levels in dogs. No specific laboratory tests required for treatment. Can be given with food. Available in multiple dosage sizes. Recommended dosage for CDS: The recommended dosage for oral administration for the control of clinical signs associated with CDS is 0.5–1.0 mg/kg once daily, preferably administered in the morning. Initially, dogs should be dosed to the nearest whole tablet. Adjustments should then be made based on response and tolerance to the drug. Recommended dosage for PDH: The recommended dosage for the control of clinical signs associated with canine PDH is 1.0 mg/kg once daily, preferably administered in the morning. If no improvement is observed after 2 months of therapy, dosage may be increased to a maximum of 2.0 mg/kg once daily. If no improvement is seen after 1 month at the higher dose or if at any time clinical signs progress, the dog should be re-evaluated. Dogs should be monitored closely for possible adverse events associated with any increase in dose. This product requires a Valid prescription. All prescription items are Non-Refundable and Non-Returnable.
